Elicio Therapeutics ELTX
NASDAQ ELTX
$3.04 -0.04 (-1.14%)
At close: Aug 21, 2026 · 4:00 PM EDT

Elicio Therapeutics (ELTX) Amortizatization of Intangibles (2024 - 2026)

Elicio Therapeutics' (ELTX) quarterly Amortizatization of Intangibles came in at $68000.0 in Q1 2026, up 94.29% YoY from $35000.0 in Q1 2025, and down 62.64% on a QoQ basis from $182000.0 in Q4 2025.

Elicio Therapeutics (ELTX) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends

Elicio Therapeutics (ELTX) has 3 years of Amortizatization of Intangibles data on file, last reported at $68000.0 in Q1 2026.

  • Quarterly Amortizatization of Intangibles rose 94.29% year-over-year to $68000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $650000.0 (up 490.91% YoY) and the FY2025 annual result came in at $217000.0, up 189.33% from the prior year.
  • Amortizatization of Intangibles retreated to $68000.0 in Q1 2026, from $182000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $400000.0 in Q3 2025 to a low of $26000.0 in Q3 2024.
  • A 3-year average of $126666.7 and a median of $58500.0 in 2024 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2025 — Amortizatization of Intangibles soared 1438.46% — and 2026, when it soared 94.29%.
  • Tracing ELTX's Amortizatization of Intangibles over 3 years: stood at $49000.0 in 2024, then surged by 271.43% to $182000.0 in 2025, then sank by 62.64% to $68000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $68000.0 (Q1 2026), $182000.0 (Q4 2025), and $400000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Elicio Therapeutics 58.41 Mn 34.91 Mn - 100,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 100,000.00
Jun 30, 2026 100,000.00
Mar 31, 2026 68,000.00
Mar 31, 2026 68,000.00
Dec 31, 2025 182,000.00
Dec 31, 2025 182,000.00
Sep 30, 2025 400,000.00
Sep 30, 2025 400,000.00
Mar 31, 2025 35,000.00
Mar 31, 2025 35,000.00
Dec 31, 2024 49,000.00
Dec 31, 2024 49,000.00
Sep 30, 2024 26,000.00
Sep 30, 2024 26,000.00